In 2023, hospital discharges for leiomyoma of the uterus in Canada stood at approximately 8.73 thousand. From 2024 to 2028, the forecast indicates a gradual decline in the number of discharges. Year-on-year, the percentage of reduction from 2024 through 2028 is about 2.34% on average. The compound annual growth rate (CAGR) over the forecasted period is approximately -2.26% per year. This downward trend suggests advancements in non-invasive treatments or preventive measures might be influencing discharge rates.
Future trends to watch for include the adoption of innovative medical technologies, improved management protocols, and the potential impact of public health initiatives aimed at early intervention and awareness, which could further reduce hospital stays.
